The Virosart® Max* product family offers a comprehensive range of advanced filtration solutions designed to meet the diverse needs of the biopharmaceutical industry, from laboratory research to large-scale manufacturing. By integrating cutting-edge filtration technologies, Virosart® Max optimizes virus removal processes, enhancing efficiency and reliability while ensuring the highest standards of product safety and quality.
Key Features
- Advanced Filtration Technology: Triple layer Polyamide membrane with 0.1 µm nominal pore size for superior filtration efficiency.
- High Adsorptive Capacity: Efficiently binds aggregates and small hydrophobic molecules effectively.
- Enhanced Membrane Protection: Protection: Increases process robustness and protects the final virus retentive membranes.
- Regulatory Compliance: Manufactured under ISO 9001 certified Quality Management System and non-pyrogenic as per USP Bacterial Endotoxins standards.
- Versatile Device Formats: Available in Minisart®, Sartolab®, Maxicaps®, Cartridge, and Maxicaps® MR format for large volume applications.
- Integrity Testing: Reliable integrity testing using Sartocheck® technology. Furthermore, each unit is integrity tested (except Minisart® and Sartolab® format, see specifications) and complies with industry standards, ensuring reliability and performance.
- Operating Parameters:
Filtration pressure: Max. 5.0 bar (72.5 psi) at 20°C; 0.5 bar (7.3 psi) at 121°C
Reversed filtration pressure: Max. 0.5 bar (7.3 psi) at 20°C
Ordering Information
- Cartridge Options: Multiple sizes; autoclavable and steamable
- Maxicaps®: Various sizes; pre-sterilized
- Midicaps®& Capsules: Sanitary connectors for easy installation; pre-sterilized
* The patented technology (DE 10 2011 105 525 B4) binds aggregates efficiently through hydrophobic interactions with polyamide, independently of process conditions such as conductivity from biological feed streams (mAbs, plasma derivates or recombinant proteins).
